A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemia.
Rees DC, Kilinc Y, Unal S, Dampier C, Pace BS, Kaya B, Trompeter S, Odame I, Mahlangu J, Unal S, Brent J, Grosse R, Fuh BR, Inusa BPD, Koren A, Leblebisatan G, Levin C, McNamara E, Meiser K, Hom D, Oliver SJ.
Rees DC, et al. Among authors: leblebisatan g.
Blood. 2022 Apr 28;139(17):2642-2652. doi: 10.1182/blood.2021013674.
Blood. 2022.
PMID: 35226723
Free article.
Clinical Trial.